Lisa Boselli
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2024
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC.
Journal: Science advances
Published: November 08, 2023
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
Journal: Journal for immunotherapy of cancer
Published: April 23, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 31, 2021
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers.
Journal: Journal for immunotherapy of cancer
Published: December 19, 2021
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 27, 2021
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 24, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer.
Journal: Cancers
Published: November 01, 2020
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer.
Journal: Translational lung cancer research
Published: July 10, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 15, 2020
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 14, 2019
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Journal: Nature communications
Published: April 04, 2019
Last Updated: 09/26/2026